Skip to main content
. Author manuscript; available in PMC: 2009 May 13.
Published in final edited form as: Int J Cancer. 2008 Sep 15;123(6):1357–1363. doi: 10.1002/ijc.23676

Figure 2.

Figure 2

Complement inhibitor expression in normal bladder and bladder carcinomas. mRNA levels of CD46, CD55 and CD59 were determined in paired normal/cancer samples by real-time RT-PCR. Graph shows fold change in the expression of each complement inhibitor in tumor sample compared to paired normal tissue sample. Mean ± SD of 3 determinations is shown. The β2-microglobulin gene was used as an internal control.